Watson Names CFO, Expands India Deal
From Bloomberg News
Watson Pharmaceuticals Inc., the No. 2 seller of oral contraceptives in the U.S., named Charles Slacik as chief financial officer and said it expanded an agreement to sell drugs made by India’s Cipla Ltd.
Slacik, 49, former CFO at medical-device maker C.R. Bard Inc., replaces Michael Boxer, who announced his resignation in November.
Shares of Corona-based Watson rose $1.10, or 3.8%, to $30.05 on the NYSE.
